RECRUITING

Social Risk Factors and Discrimination in Cancer Survivorship

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of the proposed study is to scale social risk factor screening and referral for cancer survivors and to solidify information exchange between clinical and community settings in order to improve survivor health and well-being. This will be completed through three primary aims: 1) To ascertain workflow and map community resources needed to facilitate social risk factor screening and referral for breast and prostate cancer survivors in Washington, District of Columbia. 2) To determine impact of Community Health Worker (CHW) support on Black breast and prostate cancer survivor health and wellbeing as measured through quality of life (QOL) and social connection. 3) To determine impact of anti-racism training for staff and clinicians at three cancer centers on patient-reported discrimination.

Official Title

Scaling Social Determinants of Health Screening, Social Support, and Anti-Racism Training to Reduce Inequities in Minority Cancer Survivor Health and Well-Being in Washington, D.C.

Quick Facts

Study Start:2022-05-05
Study Completion:2026-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05301114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of stage I-III breast or prostate cancer and completed curative treatment (surgery, radiation, chemotherapy) or finalized treatment plan (e.g. watch and wait); OR Stage IV breast or prostate cancer approximately 6 months from diagnosis
  2. * Black or African American race
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Hannah Arem, PhD
CONTACT
202-893-2430
hannah.arem@medstar.net
Mandi Pratt-Chapman, PhD
CONTACT
mandi@gwu.edu

Principal Investigator

Hannah Arem, PhD
PRINCIPAL_INVESTIGATOR
Medstar Health Research Institute
Mandi Pratt-Chapman, PhD
PRINCIPAL_INVESTIGATOR
George Washington University

Study Locations (Sites)

MedStar Washington Hospital Center
Washington, District of Columbia, 20010
United States

Collaborators and Investigators

Sponsor: Medstar Health Research Institute

  • Hannah Arem, PhD, PRINCIPAL_INVESTIGATOR, Medstar Health Research Institute
  • Mandi Pratt-Chapman, PhD, PRINCIPAL_INVESTIGATOR, George Washington University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-05
Study Completion Date2026-09-30

Study Record Updates

Study Start Date2022-05-05
Study Completion Date2026-09-30

Terms related to this study

Keywords Provided by Researchers

  • Health Equity
  • Community Health Worker
  • Social Support
  • Community Based Organizations
  • Social Determinants of Health
  • Breast Cancer
  • Prostate Cancer
  • Health Disparities

Additional Relevant MeSH Terms

  • Social Determinants of Health
  • Breast Cancer
  • Prostate Cancer
  • Health Equity
  • Disparities